Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...
AlphaQuest LLC cut its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 11.2% during the 4th ...
Shares of Hims & Hers rose 7.59 percent on Wednesday to finish at $33.88 apiece as investors resorted to bargain-hunting ...
We recently published a list of 10 Firms Heavily Hit by Market Pessimism. In this article, we are going to take a look at ...
Healthcare companies were flat as traders rotated into higher-risk sectors. Shares of Hims & Hers rallied after the online pharmacy said it would continue selling compounded versions of glucagon-like ...
As the U.S. stock market grapples with recent volatility, highlighted by a stumble in the nascent rally and ongoing concerns about economic uncertainty and potential recession, investors are ...
The latest trend in treating hair loss may sound familiar — essentially, it’s a repurposed drug first popularized in the ...
As U.S. stock markets show signs of recovery, with major indices like the Dow Jones and S&P 500 gaining ground amid anticipation of the Federal Reserve's economic forecasts, investors are keenly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results